DIMERIX LIMITED — Investor Relations & Filings
Dimerix Limited focuses on the development of therapeutic treatments for inflammatory diseases, with a primary emphasis on kidney and respiratory conditions. The company utilizes its proprietary Receptor-Heteromer Investigation Technology (DMX-Technology) to identify and validate G protein-coupled receptor (GPCR) targets. Its lead candidate, DMX-200, is a chemokine receptor (CCR2) antagonist currently in Phase 3 clinical trials for the treatment of Focal Segmental Glomerulosclerosis (FSGS). The company is also advancing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD) and exploring applications for diabetic kidney disease. The core strategy involves targeting multiple signaling pathways simultaneously to address unmet medical needs in chronic inflammatory and fibrotic diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Dimerix Quarterly Activities Report and Appendix 4C 10 pages 600.1KB | 2026-04-29 | English | |
| ACTION3 Statistical Review Complete 4 pages 440.7KB | 2026-04-27 | English | |
| Dimerix Releases Investor Presentation and Video Recording 26 pages 3.5MB | 2026-04-27 | English | |
| Dimerix Singapore Investor Briefing 2 pages 346.1KB | 2026-04-08 | English | |
| Dimerix to Conduct Review of ACTION3 Statistical Assumptions 3 pages 390.7KB | 2026-03-15 | English | |
| Dimerix Presents at Euroz Hartleys Institutional Conference 28 pages 3.8MB | 2026-03-15 | English |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Initiator Pharma A/S
Clinical-stage company developing drugs for central and per…
|
INIT | DK | Professional, scientific and te… |
|
Inmolecule Nanotech, S.A.
Develops nanoparticles from plant compounds for biomedical …
|
MLINA | ES | Professional, scientific and te… |
|
InNexus Biotechnology Inc.
Develops enhanced monoclonal antibodies and diagnostics usi…
|
IXSBF | CA | Professional, scientific and te… |
|
Inotiv, Inc.
A CRO providing nonclinical drug development services and r…
|
NOTV | US | Professional, scientific and te… |
|
INOVIQ LTD
Develops exosome and precision diagnostics for early cancer…
|
IIQ | AU | Professional, scientific and te… |
|
InSilico Medicine Cayman TopCo
Biotechnology company transforming drug discovery using pro…
|
3696 | KY | Professional, scientific and te… |
|
IntegraGen
Provides genomic services for cancer and rare diseases, tra…
|
ALINT | FR | Professional, scientific and te… |
|
Intellia Therapeutics, Inc.
A clinical-stage genome editing company developing therapeu…
|
NTLA | US | Professional, scientific and te… |
|
InterDigital, Inc.
An R&D company licensing foundational technologies for mobi…
|
IDCC | US | Professional, scientific and te… |
|
IntoCell, Inc.
Develops platform technologies for Antibody-Drug Conjugates…
|
287840 | KR | Professional, scientific and te… |
DIMERIX LIMITED via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/64804/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=64804 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=64804 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=64804 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 64804}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DIMERIX LIMITED (id: 64804)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.